FDA Warns Against Power Morcellators For Uterine Fibroid Surgery
This article was originally published in The Gray Sheet
Executive Summary
FDA is discouraging use of laparoscopic power morcellation as a therapy for uterine fibroids due to risk of spreading cancer tissue. The agency has instructed manufacturers to ensure that device labeling accurately displays risks; it is planning an advisory panel meeting on the topic for the summer.
You may also be interested in...
Olympus Settles Power Morcellation Suit
The company was sued by a Georgia woman who said the surgical tool allowed uterine cancer to spread throughout her abdomen. Terms of the settlement were not disclosed.
Dr. Amy Reed, Anti-Power Morcellator Activist, Dead At 44
Anesthesiologist Amy Reed, who with her cardiologist husband Hooman Noorchasm turned her battle against uterine cancer into a crusade to abolish unsafe uses of power morcellators, died May 24 at her home in Yardley, Pa., at the age of 44.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.